ArticleFrontiers in pharmacology2026
Case Report: Treatment of fulminant paraquat poisoning in a 32-week pregnant patient: a case report exploring the potential role of estrogen.
Article in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Paraquat (PQ) poisoning is a life-threatening condition characterized by severe toxicity and the absence of a specific antidote. Prognosis is strongly correlated with the ingested dose, with high-dose exposure frequently resulting in multi-organ failure and fatal outcomes. This case report presents the clinical management of a 32-week pregnant patient with fulminant PQ poisoning, a scenario typically associated with near-certain mortality. Remarkably, the patient survived, supported by a markedly elevated peak serum estradiol level of 27,000 pg/mL, which may suggest a potential cytoprotective role of elevated estrogen levels, particularly in mitigating fatal pulmonary injury-a hallmark of PQ toxicity. Following an emergency cesarean section, the neonate also survived. Crucially, toxicological analysis via liquid chromatography-tandem mass spectrometry (LC-MS/MS) detected a trace PQ concentration of 1.3 ng/mL in the neonate's blood. This finding provides definitive quantitative evidence of transplacental transfer and effectively explains the neonate's transient hepatic and renal dysfunction. This report underscores the importance of individualized treatment strategies, including oral ulcer management, psychological support, and monitoring of the unique physiological changes during pregnancy. While maternal dynamic plasma PQ monitoring was absent in this case, the confirmed transplacental fetal exposure highlights the critical need for comprehensive maternal-fetal toxicological assessments in future studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.